Winckler leaves FDA
This article was originally published in The Tan Sheet
Executive Summary
Susan Winckler, FDA chief of staff since January 2007, resigns, giving Commissioner Peggy Hamburg and the Obama administration further room to shape the agency. Winckler joined FDA as director for policy communications in September 2006, after serving as VP of policy and communications and staff counsel for the American Pharmacists Association. An August 2007 reorganization gave FDA's chief of staff a more central role and made deputy commissioners in the Office of the Commissioner report through Winckler (1"The Tan Sheet" Sept. 3, 2007)
You may also be interested in...
FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner
The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.